Kane Biotech 2017 Year End and Fourth Quarter Financial Results and Business Update

- March 22nd, 2018

Kane Biotech (TSXV:KNE) is pleased to announce its 2017 Year End and Fourth Quarter Financial Results. Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. Biofilms are thin slimy films that develop when bacteria and other microorganisms form a protective matrix that … Continued

Kane Biotech (TSXV:KNE) is pleased to announce its 2017 Year End and Fourth Quarter Financial Results. Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. Biofilms are thin slimy films that develop when bacteria and other microorganisms form a protective matrix that acts as a shield against attack.

As quoted in the press release:

Over the past year Kane Biotech has focused the majority of its resources on applications of its technology on oral care and skin care in the companion pet market, human skin disorders, and the disinfection of hard surfaces.  Kane Biotech’s objective is to license the Company’s intellectual property to strategic partners with already established large scale market and territory access.

Click here to read the full press release.

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply